{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:12:27Z","timestamp":1790802747910,"version":"4.1.0"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.addr.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T21:30:36Z","timestamp":1550784636000},"page":"245-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"special_numbering":"C","title":["Chronopharmacology of glucocorticoids"],"prefix":"10.1016","volume":"151-152","author":[{"given":"Megerle L.","family":"Scherholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis P.","family":"Androulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2019.02.004_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/ard.8.2.97","article-title":"The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocortical hormone in arthritis: preliminary report","volume":"8","author":"Hench","year":"1949","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.addr.2019.02.004_bb0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1440-1819.2009.02005.x","article-title":"Central nervous system effects of natural and synthetic glucocorticoids","volume":"63","author":"Fietta","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.addr.2019.02.004_bb0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ecl.2005.01.002","article-title":"Adrenal corticosteroid biosynthesis, metabolism, and action","volume":"34","author":"Arlt","year":"2005","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.addr.2019.02.004_bb0020","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1378\/chest.08-2408","article-title":"Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy","volume":"136","author":"Meduri","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.addr.2019.02.004_bb0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1749-6632.2002.tb04229.x","article-title":"Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity","volume":"966","author":"Elenkov","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.addr.2019.02.004_bb0035","series-title":"Comprehensive Physiology","first-page":"1273","article-title":"HPA axis-rhythms","author":"Spiga","year":"2014"},{"key":"10.1016\/j.addr.2019.02.004_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tcb.2013.07.002","article-title":"Molecular architecture of the mammalian circadian clock","volume":"24","author":"Partch","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.addr.2019.02.004_bb0045","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1126\/science.280.5369.1564","article-title":"Role of the CLOCK protein in the mammalian circadian mechanism","volume":"280","author":"Gekakis","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.addr.2019.02.004_bb0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fendo.2017.00070","article-title":"Stress-related and circadian secretion and target tissue actions of glucocorticoids: impact on health","volume":"8","author":"Nicolaides","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.addr.2019.02.004_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/2042018810380214","article-title":"Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy","volume":"1","author":"Chan","year":"2010","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2019.02.004_bb0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.yfrne.2017.12.005","article-title":"Glucocorticoid hormones are both a major circadian signal and major stress signal: how this shared signal contributes to a dynamic relationship between the circadian and stress systems","volume":"49","author":"Spencer","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1677\/joe.0.1770017","article-title":"The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system","volume":"177","author":"Buijs","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/er.2015-1080","article-title":"The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids","volume":"38","author":"Oster","year":"2017","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.addr.2019.02.004_bb0080","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.addr.2010.05.009","article-title":"Circadian rhythms in gene expression: relationship to physiology, disease, drug disposition and drug action","volume":"62","author":"Sukumaran","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0085","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2011-2879","article-title":"Sixty years after Hench--corticosteroids and chronic inflammatory disease","volume":"97","author":"Edwards","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2019.02.004_bb0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1749-6632.2009.05289.x","article-title":"Effect of novel therapeutic glucocorticoids on circadian rhythms of hormones and cytokines in rheumatoid arthritis","volume":"1193","author":"Kirwan","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0095","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/clpt.1992.80","article-title":"Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm","volume":"51","author":"Fisher","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2019.02.004_bb0100","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2147\/TCRM.S112685","article-title":"Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review","volume":"12","author":"Beltrametti","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.addr.2019.02.004_bb0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1208\/s12248-008-9038-3","article-title":"Assessment of the impact of dosing time on the pharmacokinetics\/pharmacodynamics of prednisolone","volume":"10","author":"Xu","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2019.02.004_bb0110","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use","volume":"55","author":"Curtis","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2019.02.004_bb0115","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2019.02.004_bb0120","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3899\/jrheum.100051","article-title":"Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone","volume":"37","author":"Alten","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.addr.2019.02.004_bb0125","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.clinthera.2011.10.006","article-title":"Pharmacokinetics, pharmacodynamics, and comparative bioavailability of single, oral 2-mg doses of dexamethasone liquid and tablet formulations: a randomized, controlled, crossover study in healthy adult volunteers","volume":"33","author":"Queckenberg","year":"2011","journal-title":"Clin. Ther."},{"key":"10.1016\/j.addr.2019.02.004_bb0130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ajp.2011.11071009","article-title":"Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care","volume":"169","author":"Fardet","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.addr.2019.02.004_bb0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/dmrr.2486","article-title":"Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment","volume":"30","author":"Hwang","year":"2014","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-4632.2009.04322.x","article-title":"Prevention and treatment of systemic glucocorticoid side effects","volume":"49","author":"Moghadam-Kia","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.addr.2019.02.004_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/1817-1737.65040","article-title":"Genomic and non-genomic actions of glucocorticoids in asthma","volume":"5","author":"Alangari","year":"2010","journal-title":"Ann. Thorac. Med"},{"key":"10.1016\/j.addr.2019.02.004_bb0150","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(05)17989-6","article-title":"Optimised glucocorticoid therapy: the sharpening of an old spear","volume":"365","author":"Buttgereit","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2019.02.004_bb0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1113\/expphysiol.2006.036194","article-title":"Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects","volume":"92","author":"McMaster","year":"2007","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.addr.2019.02.004_bb0160","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","article-title":"Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events","volume":"74","author":"Fardet","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2019.02.004_bb0165","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2796.2010.02218.x","article-title":"Energy regulation and neuroendocrine\u2013immune control in chronic inflammatory diseases","volume":"267","author":"Straub","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.addr.2019.02.004_bb0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000362724","article-title":"One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cruz-Topete","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.addr.2019.02.004_bb0175","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2188\/jea.JE20130035","article-title":"Associations between polymorphisms in the glucocorticoid-receptor gene and cardiovascular risk factors in a Chinese population","volume":"23","author":"Yan","year":"2013","journal-title":"J Epidemiol"},{"key":"10.1016\/j.addr.2019.02.004_bb0180","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev-physiol-021909-135821","article-title":"The mammalian circadian timing system: organization and coordination of central and peripheral clocks","volume":"72","author":"Dibner","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.addr.2019.02.004_bb0185","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1210\/jc.2018-00346","article-title":"Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study","volume":"103","author":"Venneri","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2019.02.004_bb0190","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1210\/er.2016-1083","article-title":"Circadian rhythm and sleep disruption: causes, metabolic consequences, and countermeasures","volume":"37","author":"Potter","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0195","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.addr.2010.04.005","article-title":"Chronopharmacological strategies: intra- and inter-individual variability of molecular clock","volume":"62","author":"Ohdo","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000203","article-title":"Glucocorticoids and chronotherapy in rheumatoid arthritis","volume":"2","author":"Cutolo","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.addr.2019.02.004_bb0205","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.addr.2007.07.001","article-title":"Chronobiology, drug delivery, and chronotherapeutics","volume":"59","author":"Smolensky","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.116.013441","article-title":"Systems chronotherapeutics","volume":"69","author":"Ballesta","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/17425255.4.2.175","article-title":"The influence of circadian rhythms on the kinetics of drugs in humans","volume":"4","author":"Baraldo","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.addr.2019.02.004_bb0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mce.2011.06.042","article-title":"Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis","volume":"349","author":"Kalsbeek","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0225","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1076\/jcen.24.3.335.987","article-title":"Neurophysiological and clinical aspects of glucocorticoids and memory: a review","volume":"24","author":"Alderson","year":"2002","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.addr.2019.02.004_bb0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000362736","article-title":"Stress, the stress system and the role of glucocorticoids","volume":"22","author":"Nicolaides","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.addr.2019.02.004_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1321.001","article-title":"Glucocorticoids and their actions: an introduction","volume":"1024","author":"Charmandari","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2019.02.004_bb0240","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.metabol.2010.07.012","article-title":"The role of corticosteroids and stress in chronic pain conditions","volume":"59","author":"McEwen","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.addr.2019.02.004_bb0245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neubiorev.2009.10.002","article-title":"Allostatic load biomarkers of chronic stress and impact on health and cognition","volume":"35","author":"Juster","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0250","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/0748730406293854","article-title":"SCN outputs and the hypothalamic balance of life","volume":"21","author":"Kalsbeek","year":"2006","journal-title":"J. Biol. Rhythm."},{"key":"10.1016\/j.addr.2019.02.004_bb0255","series-title":"Immunopharmacology and Inflammation","article-title":"Glucocorticoids: molecular mechanisms of action","author":"Cruz-Topete","year":"2018"},{"key":"10.1016\/j.addr.2019.02.004_bb0260","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","article-title":"The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease","volume":"132","author":"Oakley","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2019.02.004_bb0265","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/cen.12653","article-title":"Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations","volume":"82","author":"Hindmarsh","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0270","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s001340101073","article-title":"Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma","volume":"27","author":"Beishuizen","year":"2001","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.addr.2019.02.004_bb0275","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/cc2878","article-title":"Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids","volume":"8","author":"Prigent","year":"2004","journal-title":"Crit. Care"},{"key":"10.1016\/j.addr.2019.02.004_bb0280","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tins.2007.10.005","article-title":"The coming out of the brain mineralocorticoid receptor","volume":"31","author":"Joels","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.addr.2019.02.004_bb0290","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.psyneuen.2012.08.007","article-title":"Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour","volume":"38","author":"Harris","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.addr.2019.02.004_bb0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/pupt.2001.0312","article-title":"Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma","volume":"15","author":"Umland","year":"2002","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2019.02.004_bb0300","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.physiol.67.040403.120816","article-title":"Endocrinology of the stress response","volume":"67","author":"Charmandari","year":"2005","journal-title":"Annu. Rev. Physiol."},{"issue":"Suppl. 2","key":"10.1016\/j.addr.2019.02.004_bb0305","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar4687","article-title":"Circadian rhythms in rheumatology--a glucocorticoid perspective","volume":"16","author":"Spies","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.addr.2019.02.004_bb0310","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2265.2007.02812.x","article-title":"Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency","volume":"66","author":"Thomson","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0315","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.addr.2007.01.001","article-title":"Chronobiology in the endocrine system","volume":"59","author":"Haus","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0320","doi-asserted-by":"crossref","first-page":"172","DOI":"10.14310\/horm.2002.1402","article-title":"The central CLOCK system and the stress axis in health and disease","volume":"12","author":"Kassi","year":"2013","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.addr.2019.02.004_bb0325","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2019.02.004_bb0330","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ecl.2014.06.002","article-title":"Hypothalamic-pituitary-adrenal axis in HIV infection and disease","volume":"43","author":"Chrousos","year":"2014","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.addr.2019.02.004_bb0335","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tem.2007.10.005","article-title":"The hypothalamic-pituitary-adrenal axis in asthmatic children","volume":"19","author":"Priftis","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.addr.2019.02.004_bb0340","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1741-7015-9-27","article-title":"Q&A: primary generalized glucocorticoid resistance","volume":"9","author":"Chrousos","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.addr.2019.02.004_bb0345","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/eci.12426","article-title":"Chrousos syndrome: from molecular pathogenesis to therapeutic management","volume":"45","author":"Nicolaides","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.addr.2019.02.004_bb0350","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000330759","article-title":"Primary generalized glucocorticoid resistance and hypersensitivity","volume":"76","author":"Charmandari","year":"2011","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.addr.2019.02.004_bb0355","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3748\/wjg.v17.i9.1095","article-title":"Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease","volume":"17","author":"De Iudicibus","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.addr.2019.02.004_bb0360","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1677\/joe.0.1690437","article-title":"Glucocorticoid and mineralocorticoid resistance\/hypersensitivity syndromes","volume":"169","author":"Kino","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0365","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jc.2003-032026","article-title":"Glucocorticoid action networks--an introduction to systems biology","volume":"89","author":"Chrousos","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2019.02.004_bb0370","first-page":"S32","article-title":"Glucocorticoid receptor: implications for rheumatic diseases","volume":"29","author":"Kino","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.addr.2019.02.004_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102201","article-title":"Treatment with synthetic glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis","volume":"18","author":"Paragliola","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0380","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2741\/3646","article-title":"Importance of glucocorticoid receptors in upper and lower airways","volume":"15","author":"Pujols","year":"2010","journal-title":"Front Biosci. (Landmark Ed)"},{"key":"10.1016\/j.addr.2019.02.004_bb0385","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrendo.2013.183","article-title":"Glucocorticoid sensitivity in health and disease","volume":"9","author":"Quax","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0390","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nrendo.2009.106","article-title":"Stress and disorders of the stress system","volume":"5","author":"Chrousos","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0395","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/jps.10402","article-title":"Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation","volume":"92","author":"Mager","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0400","series-title":"The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease: Cushing's Syndrome and beyond","article-title":"Glucocorticoid regulation of neurocognitive and neuropsychiatric function","author":"Pereira","year":"2017"},{"key":"10.1016\/j.addr.2019.02.004_bb0405","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000069969","article-title":"Glucocorticoids and inflammation revisited: the state of the art. NIH clinical staff conference","volume":"10","author":"Franchimont","year":"2002","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.addr.2019.02.004_bb0410","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.2009.04988.x","article-title":"Glucocorticoid signaling in the cell. expanding clinical implications to complex human behavioral and somatic disorders","volume":"1179","author":"Chrousos","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0415","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbadis.2013.05.029","article-title":"Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity","volume":"1842","author":"Lee","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2019.02.004_bb0420","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.1038\/srep09442","article-title":"Glucocorticoid receptors in the locus coeruleus mediate sleep disorders caused by repeated corticosterone treatment","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2019.02.004_bb0425","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","article-title":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids","volume":"44","author":"Czock","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2019.02.004_bb0430","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.0300372101","article-title":"Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects","volume":"101","author":"Schacke","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2019.02.004_bb0435","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mce.2013.01.026","article-title":"Optimized glucocorticoid therapy: teaching old drugs new tricks","volume":"380","author":"Strehl","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0440","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/0091270003258651","article-title":"Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics","volume":"43","author":"Mager","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2019.02.004_bb0445","unstructured":"Hydrocortisone, in: L.A. Anderson (Ed.), 2017."},{"key":"10.1016\/j.addr.2019.02.004_bb0450","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40262-017-0575-8","article-title":"Predicting cortisol exposure from paediatric hydrocortisone formulation using a semi-mechanistic pharmacokinetic model established in healthy adults","volume":"57","author":"Melin","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2019.02.004_bb0455","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1210\/jc.2008-2380","article-title":"Modified-release hydrocortisone to provide circadian cortisol profiles","volume":"94","author":"Debono","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2019.02.004_bb0460","unstructured":"Prednisone, in: L.A. Anderson (Ed.)."},{"key":"10.1016\/j.addr.2019.02.004_bb0465","unstructured":"Methylprednisolone, in: L.A. Anderson (Ed.)."},{"key":"10.1016\/j.addr.2019.02.004_bb0470","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1020974408657","article-title":"Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone","volume":"27","author":"Chow","year":"1999","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.addr.2019.02.004_bb0475","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10928-007-9050-8","article-title":"A pharmacokinetic\/pharmacodynamic approach to predict total prednisolone concentrations in human plasma","volume":"34","author":"Xu","year":"2007","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.addr.2019.02.004_bb0480","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.psyneuen.2006.12.009","article-title":"Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder","volume":"32","author":"de Kloet","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.addr.2019.02.004_bb0485","unstructured":"Dexamethasone, in: L.A. Anderson (Ed.)."},{"key":"10.1016\/j.addr.2019.02.004_bb0490","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2265.2007.03011.x","article-title":"Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers","volume":"68","author":"Newell-Price","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0495","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1210\/jc.2003-030207","article-title":"The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome","volume":"89","author":"Findling","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2019.02.004_bb0500","unstructured":"Plenadren Annex I: Summary of product characteristics, Eur. Med. Agency."},{"key":"10.1016\/j.addr.2019.02.004_bb0505","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jps.20768","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: prednisolone","volume":"96","author":"Vogt","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0510","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jps.20817","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: prednisone","volume":"96","author":"Vogt","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0515","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system","volume":"58","author":"Lindenberg","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2019.02.004_bb0520","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.xphs.2018.01.025","article-title":"Solubility determination of active pharmaceutical ingredients which have been recently added to the list of essential medicines in the context of the biopharmaceutics classification system-biowaiver","volume":"107","author":"Ploger","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0525","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/00912700122012733","article-title":"Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race","volume":"41","author":"Magee","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2019.02.004_bb0530","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1177\/00912700122012742","article-title":"Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women","volume":"41","author":"Meno-Tetang","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2019.02.004_bb0535","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1993.167","article-title":"Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics","volume":"54","author":"Lew","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2019.02.004_bb0540","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/jps.22656","article-title":"Molecular basis of chronopharmaceutics","volume":"100","author":"Ohdo","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0545","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.bmcl.2013.02.015","article-title":"The mammalian clock and chronopharmacology","volume":"23","author":"Griffett","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2019.02.004_bb0550","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-015-3452-x","article-title":"Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients","volume":"152","author":"Binkhorst","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.addr.2019.02.004_bb0555","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.molmed.2016.03.004","article-title":"Dosing-time makes the poison: circadian regulation and pharmacotherapy","volume":"22","author":"Dallmann","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.addr.2019.02.004_bb0560","first-page":"4017","article-title":"Mathematical modeling of the circadian dynamics of the neuroendocrine-immune network in experimentally induced arthritis","volume":"158","author":"Rao","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2019.02.004_bb0565","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/1471-2105-11-540","article-title":"Circadian signatures in rat liver: from gene expression to pathways","volume":"11","author":"Ovacik","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.addr.2019.02.004_bb0570","first-page":"R1031","article-title":"Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle","volume":"295","author":"Almon","year":"2008","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.addr.2019.02.004_bb0575","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1124\/jpet.108.140186","article-title":"Circadian variations in rat liver gene expression: relationships to drug actions","volume":"326","author":"Almon","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2019.02.004_bb0580","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mbs.2014.10.006","article-title":"Circadian characteristics of permissive and suppressive effects of cortisol and their role in homeostasis and the acute inflammatory response","volume":"260","author":"Mavroudis","year":"2015","journal-title":"Math. Biosci."},{"key":"10.1016\/j.addr.2019.02.004_bb0585","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000342427","article-title":"Systems biology of circadian-immune interactions","volume":"5","author":"Mavroudis","year":"2013","journal-title":"J. Innate. Immun."},{"key":"10.1016\/j.addr.2019.02.004_bb0590","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physiolgenomics.00001.2012","article-title":"Entrainment of peripheral clock genes by cortisol","volume":"44","author":"Mavroudis","year":"2012","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.addr.2019.02.004_bb0595","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1152\/physiolgenomics.00026.2014","article-title":"Mathematical modeling of light-mediated HPA axis activity and downstream implications on the entrainment of peripheral clock genes","volume":"46","author":"Mavroudis","year":"2014","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.addr.2019.02.004_bb0600","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2217\/ijr.11.23","article-title":"Targeting the time of day for glucocorticoid delivery in rheumatoid arthritis","volume":"6","author":"Kirwan","year":"2011","journal-title":"Int. J. Clin. Rheumatol."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2019.02.004_bb0605","first-page":"3","article-title":"Rheumatoid arthritis: circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications","volume":"70","author":"Haus","year":"2012","journal-title":"Bull. NYU Hosp. J. Dis."},{"key":"10.1016\/j.addr.2019.02.004_bb0610","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2007.11.019","article-title":"Circadian rhythms in arthritis: hormonal effects on the immune\/inflammatory reaction","volume":"7","author":"Cutolo","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0615","first-page":"pt4","article-title":"Circadian rhythms of glucocorticoid hormone actions in target tissues: potential clinical implications","volume":"5","author":"Kino","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.addr.2019.02.004_bb0620","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/0973-3698.192680","article-title":"Modified-release prednisone in rheumatoid arthritis: rationale for chronotherapy, mechanistic considerations, and clinical implications","volume":"11","author":"Ravindran","year":"2016","journal-title":"Indian J. Rheumatol."},{"key":"10.1016\/j.addr.2019.02.004_bb0625","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2165\/00002018-200326140-00002","article-title":"Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety","volume":"26","author":"Ohdo","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.addr.2019.02.004_bb0630","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.addr.2010.03.012","article-title":"Asthma: chronopharmacotherapy and the molecular clock","volume":"62","author":"Burioka","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0635","first-page":"L1056","article-title":"Circadian molecular clock in lung pathophysiology","volume":"309","author":"Sundar","year":"2015","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.addr.2019.02.004_bb0640","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s41030-015-0001-z","article-title":"Nocturnal asthma: proof-of-concept open-label study with delayed-release prednisone","volume":"1","author":"Alavoine","year":"2015","journal-title":"Pulm. Ther."},{"key":"10.1016\/j.addr.2019.02.004_bb0645","article-title":"Recent advances in chronotherapy for the management of asthma","volume":"125","author":"Durrington","year":"2014","journal-title":"ChronoPhysiology Ther."},{"key":"10.1016\/j.addr.2019.02.004_bb0650","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1513\/AnnalsATS.201602-125FR","article-title":"Timing matters: circadian rhythm in Sepsis, obstructive lung disease, obstructive sleep apnea, and cancer","volume":"13","author":"Truong","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.addr.2019.02.004_bb0655","doi-asserted-by":"crossref","first-page":"280S","DOI":"10.1016\/S0895-7061(01)02175-6","article-title":"Circadian rhythms and clinical medicine with applications to hypertension","volume":"14","author":"Smolensky","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.addr.2019.02.004_bb0660","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/jnnp.2006.104000","article-title":"Chronotherapy using corticosteroids for multiple sclerosis relapses","volume":"78","author":"Glass-Marmor","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.addr.2019.02.004_bb0665","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1152\/physiolgenomics.00006.2016","article-title":"The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity","volume":"48","author":"Pierre","year":"2016","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.addr.2019.02.004_bb0670","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4314\/tjpr.v8i5.48091","article-title":"Chronotherapeutics and chronotherapeutic drug delivery systems","volume":"8","author":"Sajan","year":"2009","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.addr.2019.02.004_bb0675","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1211\/0022357991773294","article-title":"Chronopharmacokinetics: implications for drug treatment","volume":"51","author":"Lemmer","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2019.02.004_bb0680","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.pharmtox.47.120505.105208","article-title":"Circadian rhythms: mechanisms and therapeutic implications","volume":"47","author":"Levi","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.addr.2019.02.004_bb0685","article-title":"The importance of biological rhythms in drug treatment of hypertension and sex-dependent modifications","volume":"9","author":"Lemmer","year":"2012","journal-title":"ChronoPhysiology and Ther."},{"key":"10.1016\/j.addr.2019.02.004_bb0690","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2279-042X.108369","article-title":"Chronopharmacokinetics of drugs in toxicological aspects: a short review for pharmacy practitioners","volume":"1","author":"Erkekoglu","year":"2012","journal-title":"J. Res. Pharm. Pract."},{"key":"10.1016\/j.addr.2019.02.004_bb0695","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1152\/physiolgenomics.00106.2010","article-title":"Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology","volume":"42A","author":"Sukumaran","year":"2010","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.addr.2019.02.004_bb0700","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejps.2013.09.008","article-title":"PBPK models for the prediction of in vivo performance of oral dosage forms","volume":"57","author":"Kostewicz","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0705","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.1981.tb00538.x","article-title":"Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects","volume":"11","author":"McAllister","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2019.02.004_bb0710","first-page":"405","article-title":"Chronopharmacokinetics of dexamethasone in young subjects","volume":"46","author":"Lamiable","year":"1991","journal-title":"Therapie"},{"key":"10.1016\/j.addr.2019.02.004_bb0715","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-3-642-25950-0_10","article-title":"Molecular clocks in pharmacology","author":"Musiek","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.addr.2019.02.004_bb0720","first-page":"6","article-title":"Chronopharmacology: an overview","volume":"1","author":"Gupta","year":"2013","journal-title":"J. Ration. pharmacother. Res."},{"key":"10.1016\/j.addr.2019.02.004_bb0725","article-title":"Chronoterapuetics: targeting the disease at its ideal time","volume":"2","author":"Adil","year":"2014","journal-title":"Pharma Innov. J."},{"key":"10.1016\/j.addr.2019.02.004_bb0730","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/cen.12991","article-title":"Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information","volume":"84","author":"Chapman","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0735","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000362731","article-title":"Hypothalamic-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with different glucocorticoid approaches","volume":"22","author":"Alten","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.addr.2019.02.004_bb0740","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1210\/en.2007-0010","article-title":"Optimization of dosing schedule of daily inhalant dexamethasone to minimize phase shifting of clock gene expression rhythm in the lungs of the asthma mouse model","volume":"148","author":"Hayasaka","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.addr.2019.02.004_bb0745","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2265.2011.04074.x","article-title":"Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients","volume":"75","author":"Behan","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0750","first-page":"118","article-title":"Glucocorticoid chronotherapy: a mini-review","volume":"6","author":"Naafs","year":"2018","journal-title":"Endocrinol. Metab. Int. J."},{"key":"10.1016\/j.addr.2019.02.004_bb0755","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.beem.2008.09.010","article-title":"Novel strategies for hydrocortisone replacement","volume":"23","author":"Debono","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2019.02.004_bb0760","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-08-0874","article-title":"Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy","volume":"160","author":"Debono","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0765","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0770","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000362733","article-title":"Circadian use of glucocorticoids in rheumatoid arthritis","volume":"22","author":"Cutolo","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.addr.2019.02.004_bb0775","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/cen.12982","article-title":"Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol-binding globulin concentrations","volume":"84","author":"Chung","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0780","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/cen.12117","article-title":"What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?","volume":"78","author":"Debono","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0785","first-page":"1","article-title":"Modeling the influence of chronopharmacological administration of synthetic glucocorticoids on the hypothalamic-pituitary-adrenal axis","author":"Rao","year":"2018","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.addr.2019.02.004_bb0790","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2010-2729","article-title":"Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD","volume":"96","author":"Burt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2019.02.004_bb0795","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/cc2374","article-title":"Clinical review: corticotherapy in sepsis","volume":"8","author":"Prigent","year":"2004","journal-title":"Crit. Care"},{"key":"10.1016\/j.addr.2019.02.004_bb0800","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-8587(13)70045-7","article-title":"Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives","volume":"1","author":"Seibel","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.addr.2019.02.004_bb0805","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bonr.2017.11.001","article-title":"Osteoporotic fractures in men study research, rest-activity circadian rhythms and bone mineral density in elderly men","volume":"7","author":"Rogers","year":"2017","journal-title":"Bone Rep"},{"key":"10.1016\/j.addr.2019.02.004_bb0810","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10928-016-9492-y","article-title":"Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine","volume":"43","author":"Hartmanshenn","year":"2016","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.addr.2019.02.004_bb0815","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1210\/en.2017-00544","article-title":"Modeling the sex differences and Interindividual variability in the activity of the hypothalamic-pituitary-adrenal Axis","volume":"158","author":"Rao","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.addr.2019.02.004_bb0820","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cobeha.2016.11.016","article-title":"Individual differences in stress susceptibility and stress inhibitory mechanisms","volume":"14","author":"Ebner","year":"2017","journal-title":"Curr. Opin. Behav. Sci."},{"key":"10.1016\/j.addr.2019.02.004_bb0825","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.autrev.2005.04.019","article-title":"Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms","volume":"4","author":"Cutolo","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.addr.2019.02.004_bb0830","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054049","article-title":"Circadian timekeeping is disturbed in rheumatoid arthritis at molecular level","volume":"8","author":"Kouri","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2019.02.004_bb0835","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.3143pe36","article-title":"Stress and sex versus immunity and inflammation","volume":"3","author":"Chrousos","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.addr.2019.02.004_bb0840","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0006-3223(02)01357-4","article-title":"The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder","volume":"52","author":"Yehuda","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.addr.2019.02.004_bb0845","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-pharmtox-011613-135923","article-title":"Chronopharmacology: new insights and therapeutic implications","volume":"54","author":"Dallmann","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.addr.2019.02.004_bb0850","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2217\/pgs-2016-0151","article-title":"Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment","volume":"18","author":"Song","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.addr.2019.02.004_bb0855","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/1756283X17730748","article-title":"The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic-pituitary-adrenal axis: a retrospective observational study","volume":"10","author":"Ibrahim","year":"2017","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.addr.2019.02.004_bb0860","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000216187","article-title":"Glucocorticoid receptor in human respiratory epithelial cells","volume":"16","author":"Pujolsa","year":"2009","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.addr.2019.02.004_bb0865","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1074\/jbc.R110.179325","article-title":"Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids","volume":"286","author":"Oakley","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2019.02.004_bb0870","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.2005.02320.x","article-title":"Why is the management of glucocorticoid deficiency still controversial: a review of the literature","volume":"63","author":"Crown","year":"2005","journal-title":"Clin. Endocrinol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X19300201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X19300201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:47:55Z","timestamp":1759207675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X19300201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":174,"alternative-id":["S0169409X19300201"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2019.02.004","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronopharmacology of glucocorticoids","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}